NeoGenomics, Inc. (NEO)
18.42
+1.10
(+6.35%)
USD |
NASDAQ |
Sep 14, 16:00
18.42
0.00 (0.00%)
After-Hours: 17:02
NeoGenomics Enterprise Value : 2.518B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.518B |
| September 10, 2026 | 2.555B |
| September 09, 2026 | 2.562B |
| September 08, 2026 | 2.549B |
| September 04, 2026 | 2.526B |
| September 03, 2026 | 2.536B |
| September 02, 2026 | 2.529B |
| September 01, 2026 | 2.535B |
| August 31, 2026 | 2.594B |
| August 28, 2026 | 2.612B |
| August 27, 2026 | 2.687B |
| August 26, 2026 | 2.525B |
| August 25, 2026 | 2.451B |
| August 24, 2026 | 2.402B |
| August 21, 2026 | 2.475B |
| August 20, 2026 | 2.417B |
| August 19, 2026 | 2.433B |
| August 18, 2026 | 2.337B |
| August 17, 2026 | 2.370B |
| August 14, 2026 | 2.342B |
| August 13, 2026 | 2.399B |
| August 12, 2026 | 2.403B |
| August 11, 2026 | 2.417B |
| August 10, 2026 | 2.430B |
| August 07, 2026 | 2.422B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.293B |
| August 05, 2026 | 2.315B |
| August 04, 2026 | 2.387B |
| August 03, 2026 | 2.329B |
| July 31, 2026 | 2.259B |
| July 30, 2026 | 2.334B |
| July 29, 2026 | 2.256B |
| July 28, 2026 | 2.017B |
| July 27, 2026 | 1.984B |
| July 24, 2026 | 2.080B |
| July 23, 2026 | 2.124B |
| July 22, 2026 | 2.095B |
| July 21, 2026 | 2.151B |
| July 20, 2026 | 2.124B |
| July 17, 2026 | 2.172B |
| July 16, 2026 | 2.201B |
| July 15, 2026 | 2.158B |
| July 14, 2026 | 2.123B |
| July 13, 2026 | 2.108B |
| July 10, 2026 | 2.108B |
| July 09, 2026 | 2.187B |
| July 08, 2026 | 2.124B |
| July 07, 2026 | 2.158B |
| July 06, 2026 | 2.242B |
| July 02, 2026 | 2.242B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Precipio, Inc. | 49.39M |
| Guardant Health, Inc. | 21.67B |
| Quest Diagnostics, Inc. | 31.99B |
| Labcorp Holdings, Inc. | 31.84B |
| OPKO Health, Inc. | 1.268B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.238M |
| Revenue (Quarterly) | 201.66M |
| Total Expenses (Quarterly) | 199.42M |
| EPS Diluted (Quarterly) | 0.0171 |
| Gross Profit Margin (Quarterly) | 44.06% |
| Profit Margin (Quarterly) | 1.11% |
| Earnings Yield | -2.19% |
| Normalized Earnings Yield | -2.083 |